GENE ONLINE|News &
Opinion
Blog

Alzheimer's Disease
Biohaven’s Troriluzole Joins Long List of Failed Alzheimer’s Drugs
2021-01-21
Lilly’s Donanemab Aces Phase 2 Trial, Slows Clinical Decline in Alzheimer’s Patients
2021-01-15
Top Announcements from the J.P. Morgan Healthcare Conference 2021
2021-01-13
Biogen’s Alzheimer’s Drug Turned Down by Independent Panel
2020-11-07
Biogen Stocks Rise Following FDA’s Inspiriting Comments on Alzheimer’s Drug, Aducanumab
2020-11-05
Spotlight: An AI Method to Determine Asymptomatic COVID-19 Patients
2020-11-05
Availability of C2N’s First Blood-Based Diagnostic Marks Breakthrough in Alzheimer’s Disease
2020-10-30
Roche, AC Immune’s Alzheimer’s Drug Joins Long List of Trial Flops
2020-09-25
Vaccinex’s Drug Flounders Huntington’s Trial, but Shows Promise against Another Neurodegenerative Disease
2020-09-24
Alzheon’s Bags $47 Million from NIA for Oral Alzheimer’s Drug
2020-08-22
UCB Joins Forces with Roche to Develop Antibody Treatment for Alzheimer’s
2020-07-31
New Study Implicates an Inherited Risk Factor of Alzheimer’s Disease in Cancer Metastasis
2020-06-10
Weekly Cover: Takeda Initiates Development of Potential COVID-19 Therapy TAK-888
2020-03-13
Spotlight: Shionogi’s Big Bet on Tetra Therapeutics
2020-03-07
Biogen Stock Soars Following U-turn with their Alzheimer Drug Plans
2019-10-22
1 2 3 4 5
LATEST
Ginkgo Bioworks and Pfizer Forge $331 Million Collaboration for RNA-Based Drug Discovery
2023-09-29
Johnson & Johnson Partners with Singapore to Boost Life Sciences Innovation
2023-09-28
Vietnam and South Korea Strengthen Cooperation in Multiple Sectors
2023-09-27
PeptiDream and Genentech Collaborate on Novel Peptide-Radioisotope Drug Conjugates
2023-09-27
AcuraStem and Takeda Collaborate on Innovative ALS Treatment
2023-09-27
Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report
2023-09-27
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
EVENT
2023-10-04
BioFuture 2023
New York city,USA
Scroll to Top